-
2023-504678-39-00
4
2024-03-13
Heart Failure
-
2023-506092-10-00
4
2024-03-11
Stage III-IVA Resectable Locoregionall Advanced Head and Neck Squamous
-
2023-505499-32-00
5
2024-03-08
Uncontrolled hypertension (uTHN) defined as blood pressure that remain
-
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-506197-12-00
4
2024-02-07
Dyslipidemia
Dyslipidemias are alterations to the plasma lipid profile
-
2023-503333-22-00
5
2024-01-15
Moderate to severe controlled asthma according to Step 4 and Step 5 of
-
2023-503315-15-00
4
2023-12-20
Thrombolysis of symptomatic proximal vein thrombosis
-
2024-512650-21-00
5
2023-12-13
Thyroid Eye Disease (TED)
-
2023-506250-20-00
5
2023-12-11
ulcerative pyoderma gangrenosum
-
2022-502788-39-00
4
2023-11-27
acute myocardial infarction
-
2022-502208-64-00
4
2023-11-25
Asthma
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502778-18-00
5
2023-11-17
ulcerative colitis
-
2022-500777-14-00
4
2023-11-06
Atopic Dermatitis
-
2022-502476-23-00
4
2023-10-25
Treatment of immunotherapy-naive patients with previously untreated or
-
2022-501883-17-00
5
2023-10-16
Contrast enhancement in magnetic resonance imaging in children
-
2022-501884-41-00
5
2023-09-29
Contrast enhancement in magnetic resonance imaging for assessment of c
-
2022-501885-24-00
5
2023-09-20
Contrast enhancement in magnetic resonance imaging for assessment of n
-
2022-502174-16-00
5
2023-09-13
Macular edema secondary to retinal vein occlusion
-
2022-500746-16-00
4
2023-08-11
Geographic Atrophy
-
2023-508163-74-00
5
2023-06-12
Major Depressive Disorder
-
2023-506268-15-00
5
2023-06-05
Chronic Rhinosinusitis (CRS) in Adults
-
2024-512649-18-00
5
2023-06-05
Thyroid Eye Disease
-
2023-509747-27-00
4
2023-05-18
Heart failure